Exicure (XCUR): Company Cash on Hand

The cash liquidity metric demonstrates the business's dependence on the success of the spherical nucleic acid platform and partner payments. 0.00 captures the current value of this indicator. In the US, Exicure, Inc. (XCUR) is developing unique therapies for rare skin and neurological pathologies. However, the lack of revenue and ongoing restructuring make the financial survival of Exicure, Inc. (XCUR) entirely dependent on new strategic investments.
Exicure, Inc. (XCUR) - metric breakdowns and financial figures

Amid supply chain restructuring and a shift in research vendors, it is critical for Exicure, Inc. (XCUR) to manage liquidity to preserve its scientific assets. This metric measures the volume of available cash, determining the business's ability to fund operations without external borrowing, which allows the company's cash position to assess the balance between financial stability and capital efficiency.